Erectile dysfunction
Conditions
Interventions
Life Rejuve Intervention Group:Rejuve, orally administered 3 hours before sleep at night, one capsule per day in the first week, then once every other day in the 2nd to 4th weeks.
Contorl group:Placebo administered as those in the Life Rejuve intervention group
Sponsors
Yuquan Hospital, Tsinghua University
Eligibility
Sex/Gender
Male
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Male, aged 40-70 years; 2. With IIEF-5 score <= 20; 3. Having a stable sex partner within at least 6 months; 4. The patient volunteered to participate in the trial and signed the informed consent form; 5. With proper understanding of the requirements and content of the trial.
Exclusion criteria
Exclusion criteria: 1. Confirmed history of spine and perineal trauma; 2. History of pelvic surgery or surgery, or radiotherapy within 6 months; 3. With known history of allergy to contents of Life RejuveTM; 4. With medical or other conditions which judged by researchers as not appropriate to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change of the mean scoer of IIEF-5 erectile domain; | — |
Secondary
| Measure | Time frame |
|---|---|
| change of the mean scoer of IIEF-5 sexual desire domain;change of the mean score of IIEF-5 sexual activity domain; | — |
Countries
China
Contacts
Public ContactWu Haiyun
Department of Cardology, the First Medical Center, Chinese PLA General Hospital
Outcome results
None listed